Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) tumor expression in a Phase 1/2 study of tusamitamab ravtansine (SAR408701) in patients (pts) with advanced non-small cell lung cancer (NSCLC)
SAR-408701
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) tumor expression in a Phase 1/2 study of tusamitamab ravtansine (SAR408701) in patients (pts) with advanced non-small cell lung cancer (NSCLC) ### Output: SAR-408701